Nistatina Atb (Nystatin)

Nystatin binds to ergosterol in the cell membrane of Candida fungi. This binding creates pores that increase membrane permeability, leading to leakage of essential intracellular components and ultimately causing fungal cell death while sparing human cells that lack ergosterol.

The dosage and duration of Nistatina Atb are determined by the prescribing healthcare professional based on the severity of the infection and patient-specific factors. Patients should follow the exact instructions provided by their prescriber and the product label.

Safety data for nystatin use during pregnancy and lactation are limited. Because systemic absorption from vaginal application is minimal, it is generally considered low risk, but the prescriber should evaluate the benefit‑risk balance for each individual patient.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nystatin is a polyene antifungal that acts locally with minimal systemic absorption, making it suitable for topical vaginal use. Compared with azole antifungals, it has a different mechanism of action and is less likely to interact with systemic medications, but it may be less convenient for patients who prefer oral therapy.

Store Nistatina Atb at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct heat, and ensure the container is tightly closed to maintain product stability.

Nistatina Atb is applied intravaginally. The prescribed amount is inserted into the vagina using the supplied applicator or a clean fingertip, typically once or twice daily, as directed by the healthcare professional.

The most serious risks include severe allergic reactions such as rash, swelling, or difficulty breathing, and rare systemic symptoms like nausea or vomiting if significant absorption occurs. Patients should seek immediate medical attention if any of these symptoms develop.

Individuals with a known hypersensitivity to nystatin or any component of the formulation should avoid using Nistatina Atb. Additionally, patients with extensive vaginal ulceration or severe inflammation should consult a healthcare provider before use.